Stocks and Investing Stocks and Investing
Wed, July 7, 2021
Tue, July 6, 2021

Raghuram Selvaraju Maintained (ADMA) at Strong Buy with Decreased Target to $7 on, Jul 6th, 2021


Published on 2024-10-27 17:07:35 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Maintained "ADMA Biologics, Inc." (ADMA) at Strong Buy with Decreased Target from $10 to $7 on, Jul 6th, 2021.

Raghuram has made no other calls on ADMA in the last 4 months.



There is 1 other peer that has a rating on ADMA. Out of the 1 peers that are also analyzing ADMA, 0 agree with Raghuram's Rating of Hold.



This is the rating of the analyst that currently disagrees with Raghuram


  • Elliot Wilbur of "Raymond James" Maintained at Buy with Decreased Target to $6 on, Friday, March 26th, 2021
Contributing Sources